SCHEMBL5511656

SCHEMBL5511656

COc1ccccc1C(C(=O)O)C(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.56
POLB P06746 3/20 0.50
HTT P42858 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
PTGS1 P23219 1/20 0.49
PTGS2 P35354 1/20 0.49
AKR1C3 P42330 2/20 0.46
AKR1C2 P52895 2/20 0.46
LMNA P02545 1/20 0.46
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA12 O43570 2/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
CA14 Q9ULX7 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.44
LPAR1 Q92633 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5517091 0.84 KMT2A (0.52) KMT2APOLBHTTNPSR1L3MBTL1
SCHEMBL16713400 0.84 KMT2A (0.50) KMT2APOLBHTTNPSR1L3MBTL1
SCHEMBL9537251 0.83 KMT2A (0.42) KMT2APOLBHTTL3MBTL1SMN1; SMN2
SCHEMBL10767619 0.82 L3MBTL1 (0.42) KMT2APOLBHTTNPSR1L3MBTL1
SCHEMBL8473051 0.81 PTGS2 (0.64) KMT2APOLBHTTNPSR1L3MBTL1
SCHEMBL362211 0.81 PTGS2 (0.64) KMT2APOLBHTTNPSR1L3MBTL1
SCHEMBL7885098 0.81 PTGS2 (0.64) KMT2APOLBHTTNPSR1L3MBTL1
SCHEMBL27995420 0.81 CYP2D6 (0.52) KMT2APOLBHTTNPSR1L3MBTL1
SCHEMBL16672936 0.80 KMT2A (0.47) KMT2APOLBHTTNPSR1L3MBTL1
SCHEMBL4628923 0.79 KMT2A (0.56) KMT2APOLBHTTNPSR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed